Daconib (Dacomitinib) 45 MG – 30 TABLETS


Dacomitinib (Daconib) is used as the initial treatment for patients who have non-small cell lung cancer (NSCLC) that has spread, and who have specific genetic mutations called EGFR exon 19 deletion or exon 21 L858R substitution. Daconib, manufactured by Everest Pharmaceuticals Limited, is the generic version of Vizimpro.

Whatsapp +8801922101029